Can a Nerve-Blocking procedure outperform painkillers for cancer pain?

NCT ID NCT07761650

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study tests whether a CT-guided nerve block called celiac plexus neurolysis can relieve severe abdominal pain in people with upper gastrointestinal cancer better than standard pain medication. About 110 adults with biopsy-proven upper GI cancer and severe pain will be randomly assigned to receive either the nerve block or usual pharmacotherapy. Pain levels are measured at the start and after four weeks to see which approach offers greater relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CT-guided celiac plexus neurolysis (a procedure that uses alcohol to block pain nerves in the abdomen)
What this could lead to
If effective, this procedure could offer a more powerful and longer-lasting option for managing severe cancer-related abdominal pain, potentially reducing reliance on painkillers.
What could go wrong
The trial is relatively small and early-stage, and the procedure carries risks such as bleeding, infection, or nerve damage. Pain relief may not be better than standard medication for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UPPER ABDOMINAL MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Hospital

    Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.